Respiratory Devices Market Forecast By Top Researchers In The Industry With New Conclusions By 2025 And Global Keyplayers 3m, Astrazeneca Plc., Becton, Ge Healthcare, Koninklijke Philips N.V.

Respiratory devices help to remove mucus from the airways and improve pulmonary function. These devices increase compliance of patients suffering from respiratory diseases to daily treatment. Some of the these devices include, positive expiratory pressure, the high frequency chest wall oscillation, the oral high frequency oscillation, the intrapulmonary percussive ventilation, the incentive spirometry the flutter and the acapella and the cornet. These devices automatically adjust inhalations and exhalations according to the patient’s requirement. The devices are also available in various versions such as emergency respiratory devices for rescue application, long-term respiratory devices for intensive care, and mobile home respiratory devices.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1299

The global respiratory devices market was valued at US$ 15,143.2 million in 2016 and is expected to witness a robust CAGR of 8.8% over the forecast period (2017 - 2025).

Market Dynamics:

The major factor driving growth of the respiratory devices market include INCREASING prevalence of respiratory diseases such as COPD and asthma, increasing respiratory disease with rise in pollution level and rising geriatric population. According to the study by Global Burden of Disease, 2016, an estimated around 251 million cases of COPD were reported worldwide. According to the World Health Organization (WHO), 2015, an estimated 3.17 million deaths were caused by the disease accounting for 5% of all deaths. However, lack of awareness regarding the diseases harmful effects of certain respiratory care devices on neonates are the factors restraining respiratory devices market growth.
Increasing admissions of critical care patients in Intensive Care Units (ICU) is expected to fuel the market growth
Increasing prevalence of chronic respiratory diseases such as asthma, chronic pulmonary lung disease, pulmonary hypertension, and occupational lung disease are the major factors augmenting growth of the respiratory devices market, owing to the pronounced need of therapeutic respiratory devices in the medical as well as in the homecare settings. According to the World Health Organization (WHO), in 2017, asthma is a major non communicable disease with an estimated 235 million people suffering from the condition. According to the American Academy of Allergy Asthma and Immunology, 2015, an estimated number of people suffering from asthma is expected to increase by more than 100 million by 2025.

North America is expected to dominate the respiratory devices market, owing to increasing number of hospitalizations and emergency visits associated with acute or life threatening medical problems. According to the study by Society of Critical Care Medicine 2016, more than 5.7 million patients are admitted annually to intensive care units (ICUs) in the U.S. for support of airway, breathing or circulation, and comprehensive management of injury. Also, According to the Centers of Disease Control and Prevention (CDC), 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were registered in the U.S. hospital facilities. However, stringent FDA approvals, lack of awareness about innovative devices and unaffordable or high cost of respiratory devices are the factors restraining growth of the respiratory devices market.

Competitive Analysis:

• Koninklijke Philips N.V.,
• 3M,
• AstraZeneca Plc.,
• GE Healthcare,
• GlaxoSmithKline Plc.,
• Medtronic plc,
• Becton,
• Dickinson and Company,
• Invacare Corporation,
• ResMed Inc.,
• CareFusion Corporation.

Inquire Here Before Purchase Of This Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1299

Detailed Segmentation:

• Global Respiratory Devices Market, By Product Type:
◦ Therapeutic Devices
▪ Positive Airway Pressure (PAP) Devices
• Continuous PAP Devices
• Automatic PAP Devices
• Bi-level PAP Devices

▪ Inhalers
• Metered Dose Inhalers
• Dry Powder Inhalers
• Nebulizers

▪ Humidifiers
• Heated Humidifiers
• Passover Humidifiers

▪ Oxygen Concentrators
• Fixed Oxygen Concentrators
• Portable oxygen Concentrators

▪ Reusable Resuscitators
▪ Respiratory masks
▪ Ventilators
▪ Nitric Oxide Delivery Units
▪ Others

◦ Monitoring Devices
▪ Pulse Oximeters
▪ Capnographs
▪ Gas Analyzers

◦ Diagnostic Devices
▪ Spirometer
▪ Peak Flow Meters
▪ Polysomnography Devices
▪ Others

• Global Respiratory Devices Market, By Geography:
◦ North America
◦ Latin America
◦ Europe
◦ Asia Pacific
◦ Middle East
◦ Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.